[ACRX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 945.96%
YoY- 817.32%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 252 507 570 442 2 1,862 -
PBT 64 -7,485 -6,739 70,666 -8,674 -7,917 -8,375 -
Tax -5,273 -1 11 3 -321 467 796 -
NP 5,337 -7,484 -6,750 70,663 -8,353 -7,917 -8,375 -
Tax Rate 8,239.06% - - -0.00% - - - -
Total Cost -5,337 7,736 7,257 -70,093 8,795 7,919 10,237 -
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 -2,969.84 -1,331.36 12,397.02 -1,889.82 -395,850.00 -449.79 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS 0.49 -1.01 -0.91 9.60 -1.15 -1.24 -1.40 -
EPS Diluted 0.49 -1.01 -0.91 9.60 -1.15 -1.24 -1.40 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.